Teva filed a new drug application to market a generic version of Actonel, the osteoporosis drug in the U.S., asserting that Read the rest of this entry »
Teva’s Fails to Invalidate Proctor & Gamble’s Patent for Actonel
March 2, 2008
Leave a Comment » | 
drugs, Intellectual Property, Israel IP, Israel Related, News, Patents, pharmaceuticals, pharmaceuticals and Biotechnology | 
Permalink
Posted by Dr Michael Factor
